Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test

British Journal of Clinical Pharmacology

Volumn 45, Issue 2, 1998, Pages 176-178

  Parker, A C ^a   Pritchard, P ^a   Preston, T ^b   Choonara, I ^a,c  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^b SCOTTISH UNIVERSITIES ENVIRONMENTAL RESEARCH CENTRE   (United Kingdom)

^c DERBYSHIRE CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Caffeine; Caffeine breath test; Carbamazepine; Children; CYP1A2; Enzyme induction

Indexed keywords

ANALGESIC AGENT; CAFFEINE; CARBAMAZEPINE; CARBON DIOXIDE; CENTRAL STIMULANT AGENT; CYTOCHROME P450 1A2; DIAGNOSTIC AGENT; CYTOCHROME P450 ISOENZYME;

ADOLESCENT; ARTICLE; BREATH ANALYSIS; BREATHING; CHILD; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; EPILEPSY; FEMALE; HUMAN; MALE; METABOLISM; METHODOLOGY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INDUCTION; LIVER MICROSOME METABOLISM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADOLESCENT; ANALGESICS, NON-NARCOTIC; BREATH TESTS; CAFFEINE; CARBAMAZEPINE; CARBON DIOXIDE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CYTOCHROME P-450 CYP1A2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EPILEPSY; FEMALE; HUMANS; MALE; RESPIRATION;

EID: 0031594230     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00684.x     Document Type: Article

References (17)

1. Levy RH, Wurden CJ. Carbamazepine interactions with other drugs. In Antiepileptic Drugs, 4th edition (eds) Levy RH, Mattson RH, Meldrum BS. New York: Raven Press 1995; 543-554.
2. Crawford P, Chadwick DJ, Martin C, Tjia J, Back DJ, Orme M. The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids. Br J Clin Pharmacol 1990; 30: 892-896.
3. Penttila O, Neuvonen PJ, Aho K, Lehtovaara R. Interaction between doxycycline and some antiepileptic drugs. Br Med J 1974; 2: 470-472.
4. 2 Breath Test. Dev Pharmacol Ther 1989; 12: 90-95.
5. 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin. Clin Pharmacol Ther 1992; 52: 170-180.
6. Parker AC, Preston T, Heaf D, Kitteringham NR, Choonara I. Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test. Br J Clin Pharmacol 1994; 38: 573-576.
7. Parker AC, Pritchard P, Preston T, Dalzell AM, Choonara I. Lack of inhibitory effect of cimetidine on caffeine metabolism in children using the caffeine breath test. Br J Clin Pharmacol 1997; 43: 467-470.
8. 2 breath tests: methodology and fundamental considerations. J Lab Clin Med 1977; 90: 412-421.
9. Preston T, McMillan DC. Rapid sample throughput for biomedical stable isotope tracer studies. Biomedical and Environmental Mass Spectrometry 1988; 16: 229-235.
10. Craig H. The geochemistry of stable carbon isotopes. Geochimica Cosmochimica Acta 1957; 3: 53-92.
11. 2 breath tests as monitors of cytochrome P-450 dependent mixed function mono-oxygenase system in metabolism. In Developmental Pharmacology, (eds) Macleod SM, Okey L, Spielberg SP. 1983; pp 119-145, Liss, New York.
12. Pichard L, Fabre I, Fabre G, et al. Cyclosporin A drug interactions. Drug Metab Dispos 1990; 18: 595-606.
13. Wietholtz H, Zysset TH, Kreiten K, Dohl D, Büchsel R, Matern S. Effect of phenytoin, carbamazepine and valproic acid on caffeine metabolism. Eur J Clin Pharmacol 1989; 36: 401-406.
14. Kalow W, Tang BK. The use of caffeine for enzyme assays: A critical appraisal. Clin Pharmacol Ther 1993; 53: 503-514.
15. Rasmussen BB, Brosen K. Theophylline has no advantage over caffeine as a putative model drug for assessing CYP1A2 activity in humans. Br J Clin Pharmacol 1997; 43: 253-258.
16. PA (P-450 1A2), the phenacetin 0-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA 1989; 86: 7696-7700.
17. Lambert GH, Schoeller DA, Kotake AN, Flores C, Hay D. The effect of age, gender and sexual maturation on the caffeine breath test. Dev Pharmacol Ther 1986; 9: 375-368.